← FDA DRUG APPROVALS

FDA ANDA · ANDA077436

FLUNISOLIDE

Sponsor: APOTEX

APPLICATION
ANDA077436
TYPE
ANDA
ORIGINAL APPROVAL
2007-08-09
LATEST ACTION
2007-08-09
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Discontinued

Products

FLUNISOLIDEDiscontinued
FLUNISOLIDE 0.029MG/SPRAY · SPRAY, METERED · NASAL

Approval history

2007-08-09OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →